Specifically, two Treg subpopulations, the CCR7 and CD74 Treg subgroups, are associated with type I interferon-induced dysfunction in SLE patients, suggesting that specific pathways in lupus need to be targeted. The gene discussed is CCR7; the disease is systemic lupus erythematosus.